Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2003 3
2004 5
2005 4
2006 7
2007 8
2008 9
2009 7
2010 4
2011 7
2012 4
2013 7
2014 6
2015 3
2016 4
2017 11
2018 14
2019 6
2020 17
2021 1
Text availability
Article attribute
Article type
Publication date

Search Results

119 results
Results by year
Filters applied: . Clear all
Page 1
The value of antimicrobial peptides in the age of resistance.
Magana M, Pushpanathan M, Santos AL, Leanse L, Fernandez M, Ioannidis A, Giulianotti MA, Apidianakis Y, Bradfute S, Ferguson AL, Cherkasov A, Seleem MN, Pinilla C, de la Fuente-Nunez C, Lazaridis T, Dai T, Houghten RA, Hancock REW, Tegos GP. Magana M, et al. Among authors: cherkasov a. Lancet Infect Dis. 2020 Sep;20(9):e216-e230. doi: 10.1016/S1473-3099(20)30327-3. Epub 2020 Jul 9. Lancet Infect Dis. 2020. PMID: 32653070 Review.
ETS transcription factors as emerging drug targets in cancer.
Hsing M, Wang Y, Rennie PS, Cox ME, Cherkasov A. Hsing M, et al. Among authors: cherkasov a. Med Res Rev. 2020 Jan;40(1):413-430. doi: 10.1002/med.21575. Epub 2019 Mar 29. Med Res Rev. 2020. PMID: 30927317 Review.
Ivermectin inhibits HSP27 and potentiates efficacy of oncogene targeting in tumor models.
Nappi L, Aguda AH, Nakouzi NA, Lelj-Garolla B, Beraldi E, Lallous N, Thi M, Moore S, Fazli L, Battsogt D, Stief S, Ban F, Nguyen NT, Saxena N, Dueva E, Zhang F, Yamazaki T, Zoubeidi A, Cherkasov A, Brayer GD, Gleave M. Nappi L, et al. Among authors: cherkasov a. J Clin Invest. 2020 Feb 3;130(2):699-714. doi: 10.1172/JCI130819. J Clin Invest. 2020. PMID: 31845908 Free PMC article.
QSAR modeling: where have you been? Where are you going to?
Cherkasov A, Muratov EN, Fourches D, Varnek A, Baskin II, Cronin M, Dearden J, Gramatica P, Martin YC, Todeschini R, Consonni V, Kuz'min VE, Cramer R, Benigni R, Yang C, Rathman J, Terfloth L, Gasteiger J, Richard A, Tropsha A. Cherkasov A, et al. J Med Chem. 2014 Jun 26;57(12):4977-5010. doi: 10.1021/jm4004285. Epub 2014 Jan 6. J Med Chem. 2014. PMID: 24351051 Free PMC article.
QSAR without borders.
Muratov EN, Bajorath J, Sheridan RP, Tetko IV, Filimonov D, Poroikov V, Oprea TI, Baskin II, Varnek A, Roitberg A, Isayev O, Curtarolo S, Fourches D, Cohen Y, Aspuru-Guzik A, Winkler DA, Agrafiotis D, Cherkasov A, Tropsha A. Muratov EN, et al. Among authors: cherkasov a. Chem Soc Rev. 2020 Jun 7;49(11):3525-3564. doi: 10.1039/d0cs00098a. Epub 2020 May 1. Chem Soc Rev. 2020. PMID: 32356548 Review.
Moving Towards Precision Urologic Oncology: Targeting Enzalutamide-resistant Prostate Cancer and Mutated Forms of the Androgen Receptor Using the Novel Inhibitor Darolutamide (ODM-201).
Borgmann H, Lallous N, Ozistanbullu D, Beraldi E, Paul N, Dalal K, Fazli L, Haferkamp A, Lejeune P, Cherkasov A, Gleave ME. Borgmann H, et al. Among authors: cherkasov a. Eur Urol. 2018 Jan;73(1):4-8. doi: 10.1016/j.eururo.2017.08.012. Epub 2017 Aug 26. Eur Urol. 2018. PMID: 28851578
Computer-Aided Ligand Discovery for Estrogen Receptor Alpha.
Bafna D, Ban F, Rennie PS, Singh K, Cherkasov A. Bafna D, et al. Among authors: cherkasov a. Int J Mol Sci. 2020 Jun 12;21(12):4193. doi: 10.3390/ijms21124193. Int J Mol Sci. 2020. PMID: 32545494 Free PMC article. Review.
Functional analysis of androgen receptor mutations that confer anti-androgen resistance identified in circulating cell-free DNA from prostate cancer patients.
Lallous N, Volik SV, Awrey S, Leblanc E, Tse R, Murillo J, Singh K, Azad AA, Wyatt AW, LeBihan S, Chi KN, Gleave ME, Rennie PS, Collins CC, Cherkasov A. Lallous N, et al. Among authors: cherkasov a. Genome Biol. 2016 Jan 26;17:10. doi: 10.1186/s13059-015-0864-1. Genome Biol. 2016. PMID: 26813233 Free PMC article.
119 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page